- Home
- PCVX vs PTCT Comparison
PCVX vs PTCT Comparison
Compare PCVX & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- PTCT
- Stock Information
- Founded
- PCVX 2013
- PTCT 1998
- Country
- PCVX United States
- PTCT United States
- Employees
- PCVX N/A
- PTCT N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- PCVX Health Care
- PTCT Health Care
- Exchange
- PCVX Nasdaq
- PTCT Nasdaq
- Market Cap
- PCVX 6.0B
- PTCT 5.3B
- IPO Year
- PCVX 2020
- PTCT 2013
- Fundamental
- Price
- PCVX $49.03
- PTCT $75.70
- Analyst Decision
- PCVX Strong Buy
- PTCT Buy
- Analyst Count
- PCVX 7
- PTCT 17
- Target Price
- PCVX $101.67
- PTCT $73.24
- AVG Volume (30 Days)
- PCVX 1.3M
- PTCT 1.1M
- Earning Date
- PCVX 11-04-2025
- PTCT 11-04-2025
- Dividend Yield
- PCVX N/A
- PTCT N/A
- EPS Growth
- PCVX N/A
- PTCT N/A
- EPS
- PCVX N/A
- PTCT 8.94
- Revenue
- PCVX N/A
- PTCT $1,779,150,000.00
- Revenue This Year
- PCVX N/A
- PTCT $119.02
- Revenue Next Year
- PCVX N/A
- PTCT N/A
- P/E Ratio
- PCVX N/A
- PTCT $8.42
- Revenue Growth
- PCVX N/A
- PTCT 97.54
- 52 Week Low
- PCVX $27.66
- PTCT $35.95
- 52 Week High
- PCVX $98.17
- PTCT $76.80
- Technical
- Relative Strength Index (RSI)
- PCVX 69.14
- PTCT 79.67
- Support Level
- PCVX $40.14
- PTCT $69.23
- Resistance Level
- PCVX $45.90
- PTCT $73.98
- Average True Range (ATR)
- PCVX 2.30
- PTCT 2.67
- MACD
- PCVX 0.26
- PTCT 0.40
- Stochastic Oscillator
- PCVX 91.15
- PTCT 89.08
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.